Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model

Tuberculosis

Volumn 93, Issue 3, 2013, Pages 373-380

  Zucchi, Fabíola C R ^a,b   Tsanaclis, Ana Maria C ^c   Moura Dias Jr , Quintino ^a   Silva, Célio L ^a   Pelegrini Da Silva, Adriana ^d   Neder, Luciano ^a   Takayanagui, Osvaldo M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DO ESTADO DE MATO GROSSO   (Brazil)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cerebellum; DNA hsp65 vaccine; Murine model; Tuberculosis; VEGF (vascular endothelial growth factor)

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN 65; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBELLUM; CONTROLLED STUDY; DRUG EFFICACY; GRANULOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

ANIMALS; BACTERIAL PROTEINS; CEREBELLAR DISEASES; CEREBELLUM; CHAPERONIN 60; DISEASE MODELS, ANIMAL; IMMUNIZATION SCHEDULE; MALE; MICE; MYCOBACTERIUM BOVIS; TUBERCULOMA, INTRACRANIAL; TUBERCULOSIS VACCINES; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM; TUBERCULOSIS, MENINGEAL; VACCINES, DNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875809954     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.02.002     Document Type: Article

References (60)

1. F. Alatas, Ö. Alatas, M. Metintas, A. Özarslan, S. Erginel, and H. Yilldirim Vascular endothelial growth factor levels in active pulmonary tuberculosis Chest 124 2004 2156 2159
2. A.T. Argaw, L. Asp, J. Zhang, K. Navrazhina, T. Pham, J.N. Mariani, S. Mahase, D.J. Dutta, J. Seto, E.G. Kramer, N. Ferrara, M.V. Sofroniew, and G.R. John Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease J Clin Invest 122 7 Jul 2 2012 2454 2468 10.1172/JCI60842 [Epub 2012 Jun 1]
3. J. Azami, M.B. Llewelyn, and M.H. Roberts An extra-fine assembly for intracerebral microinjection J Physiol (Lond) 303 1980 18 19
4. S.L. Baldwin, C. D'Souza, A.D. Roberts, B.P. Kelly, A.A. Frank, M.A. Lui, J.B. Ulmer, K. Huygen, D.M. McMurray, and I.M. Orme Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis Infect Immun 66 6 1998 2951 2959
5. N.A. Be, G. Lamichhane, J. Grosset, S. Tyagi, Q.-J. Cheng, K.S. Kim, W.R. Bishai, and S.K. Jain Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system JID 198 2008 1520 1527
6. D.T. Connolly, D.M. Heuvelman, R. Nelson, J.V. Olander, B.L. Eppley, J.J. Delfino, N.R. Siegel, R.M. Leimgruber, and J. Feder Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Invest 84 5 1989 1470 1478
7. J.B. Coulter, R.L. Baretto, C.L. Mallucci, M.I. Romano, L.J. Abernethy, D.M. Isherwood, D.S. Kumararatne, and D.A. Lammas Tuberculous meningitis: protracted course and clinical response to interferon-gamma Lancet Infect Dis 7 3 2007 225 232
8. M. Cows, G. Thwaites, S. Dunstan, T.R. Hawn, N.T.N. Lan, and N.T.T. Thuong The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis PLoS Pathog 4 2008 3
9. S.D. Croll, J.H. Goodman, and H.E. Scharfman Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword Adv Exp Med Biol 548 2004 57 68
10. S.D. Croll, R.M. Ransohoff, N. Cai, Q. Zhang, F.J. Martin, T. Wei, L.J. Kasselman, J. Kintner, A.J. Murphy, G.D. Yancopoulos, and S.J. Wiegand VEGF-mediated inflammation precedes angiogenesis in adult brain Exp Neurol 187 2 2004 388 402
11. A.V. Deepak, and B.P. Salimath Antiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF-κB and caspase activated DNase in ascites tumor model Biochimie 88 2006 297 307
12. S.A. dos Santos, C.R. Zárate-Bladés, F.C. de Sá Galetti, I.T. Brandão, A.P. Masson, E.G. Soares, A.P. Araújo, and C.L. Silva A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection Hum Vaccin 6 12 2010 1047 1053
13. H.F. Dvorak, T.M. Sioussat, L.F. Brown, B. Berse, J.A. Nagy, A. Sorrel, E.J. Manseau, L. Van de Walter, and D. Senger Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels J Exp Med 174 1991 1275 1278
14. D. Elias, D. Markovits, T. Reshef, R. van der Zee, and I.R. Cohen Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein Proc Natl Acad Sci USA 87 1990 1576 1580
15. P.F. Fedatto, C.A. Sérgio, M.O. Paula, A.F. Gembre, L.H. Franco, P.F. Wowk, S.G. Ramos, C. Horn, G. Marchal, W.M. Turato, C.L. Silva, D.M. da Fonseca, and V.L. Bonato Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+)/CD4(+) Foxp3(+) cells Immunology 137 3 2012 Nov 239 248 10.1111/imm.12006
16. N. Ferrara, and W.J. Henzel Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem Biophys Res Commun 161 1989 851 858
17. I. Flamme, G. Breier, and W. Risau Vascular endothelial growth factor (VEGF) and VEGF receotor 2(flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embrio Dev Biol 169 1995 699 712
18. M. van der Flier, S. Hoppenreijs, A.J. Rensburg Van, M. Ruyken, A.H.J. Kolk, P. Springer, A.I.M. Hoepelman, S.P.M. Geelen, J.L.L. Kimpen, and J.F. Schoelman Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis Ped Infect Dis J 23 7 2004 608 613
19. F. Forstreuter, R. Lucius, and R. Mentlein Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells J Neuroimunology 132 2002 93 98
20. F. Gray, and J.-M. Alonso Bacterial infections of the central nervous system 7th ed. D.I. Graham, P.L. Lantos, Greenfield's neuropathology vol. II 2002 Arnold London 171
21. K.A. Houck, D.W. Leung, A.M. Rowland, J. Winer, and N. Ferrara Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms J Biol Chem 267 36 1992 26031 26037
22. N. Husain, S. Awasthi, M. Haris, R.K. Gupta, and M. Husain Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis J Infect 56 2 2008 Feb 114 119 [Epub 2007 Dec 26]
23. A. Ishikawa, H. Yoshida, N. Metoki, T. Toki, T. Imaizumi, T. Matsumiya, K. Yamashita, K. Taima, and K. Satoh Edaravone inhibits the expression of vascular endothelial growth factor inhuman astrocytes exposed to hypoxia Neurosci Res 59 4 2007 406 412
24. K.M. Lima, V.L. Bonato, L.H. Faccioli, I.T. Brandão, S.A. dos Santos, and A.A. Coelho-Castelo Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice Vaccine 19 2001 3518 3525
25. J.C. Lorenzi, A.P. Trombone, C.D. Rocha, L.P. Almeida, R.L. Lousada, T. Malardo, I.C. Fontoura, R.A. Rossetti, A.F. Gembre, A.M. Silva, C.L. Silva, and A.A. Coelho-Castelo Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis BMC Biotechnol 10 2010 Oct 20 77 10.1186/1472-6750-10-77
26. D.B. Lowrie, R.E. Tascon, M.J. Colston, and C.L. Silva Towards a DNA vaccine against tuberculosis Vaccine 12 1994 1537 1540
27. D.B. Lowrie, C.L. Silva, M.J. Colston, S. Ragno, and R.E. Tascon Protection against tuberculosis by plasmid DNA vaccine Vaccine 15 1997-a 834 838
28. D.B. Lowrie, C.L. Silva, and R.E. Tascon DNA vaccines against tuberculosis Immunol Cell Biol 75 6 1997-b 591 594
29. D.B. Lowrie, C.L. Silva, and R.E. Tascon Genetic vaccination against tuberculosis Springer Semin Immunopathol 19 2 1997-c 161 173
30. D.B. Lowrie, R.E. Tascon, V.L.D. Bonato, V.M.F. Lima, L.H. Faccioli, E. Stavropoulos, M.J. Colston, R.G. Hewinson, K. Moelling, and C.L. Silva Therapy of tuberculosis in mice by DNA vaccination Nature 400 15 1999 269 271
31. E. Lozes, K. Huygen, J. Content, O. Denis, D.L. Montgomery, A.M. Yawman, P. Vandenbussche, J.P. Van Vooren, A. Drowart, J.B. Ulmer, and M.A. Liu Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex Vaccine 15 8 1997 830 833
32. K.V. Lukcas, D.B. Lowrie, R.W. Stokes, and M.J. Colston Tumor cells transfected with a bacterial heat shock gene lose tumorigenicity and induce protection against tumors J Exp Med 178 1993 343 348
33. W. Matsuyama, T. Hashigughi, K. Matsumuro, F. Iwami, Y. Hirotsu, M. Kuwabata, K. Arimura, and M. Osame Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis Am J Respir Crit Care Med 162 2000 1120 1122
34. A.R. Martins, C.A. Zanella, F.C. Zucchi, T.C. Dombroski, E.T. Costa, L.M. Guethe, A.O. Oliveira, A.L. Donatti, L. Neder, L. Chimelli, G. De Nucci, P. Lee-Ho, and F. Murad Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells J Neurosci Methods 198 1 2011 16 22
35. W. Matsuyama, T. Hashigughi, F. Umehara, E. Matsuura, M. Kawabata, K. Arimura, I. Maruiyama, and M. Osame Expression of vascular endothelial growth factor in turberculous meningitis J Neurol Sci 186 2001 75 79
36. R. Mazzolla, M. Puliti, R. Barluzzi, R. Neglia, F. Bistoni, G. Barbolini, and E. Blasi Differential microbial clearance and immunoresponse of Balb/c (Nramp1 susceptible) and DBA2 (Nramp1 resistant) mice intracerebrally infected with Mycobacterium bovis BCG (BCG) FEMS Immunol Med Microbiol 32 2002 149 158
37. P. Michaluart, K.A. Abdallah, F.D. Lima, R. Smith, R.A. Moysés, V. Coelho, G.D. Victora, A. Socorro-Silva, E.C. Volsi, C.R. Zárate- Bladés, A.R. Ferraz, A.K. Barreto, M.C. Chammas, R. Gomes, E. Gebrim, L. Arakawa-Sugueno, K.P. Fernandes, P.A. Lotufo, M.R. Cardoso, J. Kalil, and C.L. Silva Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck Cancer Gene Ther 15 10 2008 Oct 676 684 10.1038/cgt.2008.35 [Epub 2008 Jun 6]
38. A. Mihret, Y. Bekele, K. Bobosha, M. Kidd, A. Aseffa, R. Howe, and G. Walzl Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection J Infect 2012 Nov 20 10.1016/j.jinf.2012.11. 005 pii: S0163-4453(12)00339-8 [Epub ahead of print]
39. U.K. Misra, J. Kalita, and P.K. Maurya Stroke in tuberculous meningitis J Neurol Sci 303 1-2 2011 Apr 15 22 30 10.1016/j.jns.2010.12.015 [Epub 2011 Jan 26]
40. U.K. Misra, J. Kalita, A.P. Singh, and S. Prasad Vascular endothelial growth factor in tuberculous meningitis Int J Neurosci 29 2012 Nov [Epub ahead of print]
41. A. Nakamura-Ishizu, T. Kurihara, Y. Okuno, Y. Ozawa, K. Kishi, N. Goda, K. Tsubota, H. Okano, T. Suda, and Y. Kubota The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner Dev Biol 363 1 Mar 1 2012 106 114
42. H. Nomaguchi, Y. Yogi, K. Kawatsu, H. Okamura, Y. Ozawa, and T. Kasatani Prevention of diabetes in non-obese diabetic mice by a single immunization with Mycobacterium leprae Nihon Hansenbyo Gakkai Zasshi 71 1 2002 Feb 31 38
43. A. Pelegrini-da-Silva, A.R. Martins, and W.A. Prado A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor mediated modulation of nociception Neurosci 132 2005 453 463
44. A. Rambukkana, J.D. Burggraaf, W.R. Faber, M. Harboe, P. Teeling, S. Krieg, and P.K. Das The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues Infect Immun 61 5 1993 1835 1845
45. C. Rodríguez-Narciso, M. Pérez-Tapia, R.M. Rangel-Cano, C.L. Silva, M. Meckes-Fisher, R. Salgado-Garciglia, S. Estrada-Parra, R. López-Gómez, and I. Estrada-García Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis Transgenic Res 20 2 2011 Apr 221 229 10.1007/s11248-010-9404-7 [Epub 2010 Jun 6]
46. D.R. Senger, D.T. Connolly, L. Van de Water, J. Feder, and H.F. Dvorak Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor Cancer Res 50 6 1990 Mar 15 1774 1778
47. D.R. Senger, S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 4587 Feb 25 1983 983 985
48. D.R. Senger, C.A. Perruzzi, J. Feder, and H.F. Dvorak A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines Cancer Res 46 1986 5629 5632
49. D.L. Sewell, E.K. Reinke, L.H. Hogan, M. Sandor, and Z. Fabry Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections Immunol Lett 82 1-2 2002 Jun 3 101 110
50. I.M. Siqueira, A.M. Ribeiro, Y.K. de Medeiros Nóbrega, K.S. Simon, A.C. Souza, M.S. Jerônimo, F.F. Neto, C.L. Silva, M.S. Felipe, and A.L. Bocca DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by fonsecaea pedrosoi Mycopathologia 22 2012 Nov [Epub ahead of print]
51. R.E. Tascon, M.J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D.B. Lowrie Vaccination against tuberculosis by DNA injection Nat Med 2 1996 888 892
52. G. Thwaites, T.T.H. Chau, N.T.H. Mai, F. Drobniewski, K. McAdam, and J. Farrar Tuberculous meningitis J Neurol Neurosurg Psychiatry 68 2000 289 299
53. G.E. Thwaites, and T.T. Hien Tuberculous meningitis: many questions, too few answers Lancet Neurol 4 2005 160 170
54. L. Tsenova, A. Bergtold, V.H. Freedman, R.A. Young, and G. Kaplan Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system Proc Natl Acad Sci USA 96 1999 5657 5662
55. WHO (World Health Organization) WHO report 2010 2011 Global Tuberculosis Control
56. D. Young, and C. Dye The development and impact of tuberculosis vaccines Cell 124 2006 683 687
57. J. Zhang, B. Peng, and C. Xinming Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome Clin Cancer Res 11 20 2005 7334 7343
58. X.J. Zhu, N. Venkataprasad, H.S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H.M. Vondermeier Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection J Immunol 158 12 1997 5921 5926
59. F.C.R. Zucchi, A. Pelegrini-da-Silva, L. Neder, C.L. Silva, A.M. Tsanaclis, and O.M. Takayanagui The contribution of a murine CNS-TB model for the understanding of the host-pathogen interactions in the formation of granulomas J Neurosci Methods 206 1 2012 88 93
60. C. Riou, B. Perez Peixoto, L. Roberts, K. Ronacher, G. Walzl, C. Manca, R. Rustomjee, T. Mthiyane, D. Fallows, C.M. Gray, and G. Kaplan Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis PLoS One 7 5 2012 e36886